The 340B Drug Pricing Program (340B Program) is no stranger to controversy. We have previously covered the ongoing contract pharmacy legal battles and the new alternative dispute resolution process.

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved patients by requiring pharmaceutical companies to offer prescription discounts ...

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the Health, Education, Labor and Pensions Committee appear to agree that ...

The CMS proposed a rule on Thursday that would slash Medicare payment rates for a program that hospitals use to buy discounted drugs and implement site-neutral payments for some imaging services next ...

As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it. The 340B Drug Pricing ...

A federal judge granted a temporary restraining order to block a pilot program aimed at keeping better tabs on the federal 340B hospitals use to receive drug discounts. The pilot was scheduled to ...

The Department of Health and Human Services is dropping the 340B Rebate Model Pilot but could potentially restart the administrative process for the program, according to a court filing. A federal ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

Alissa D. Fleming, Gregory M. Fliszar Ph.D. In the fall of 2024, several pharmaceutical companies – specifically, Eli Lilly and Company, Sanofi-Aventis U.S. LLC, Bristol Myers Squibb Company, and ...

The pharmaceutical industry and Colorado’s hospitals agree that a federal program intended to reduce the cost of outpatient medications has evolved into something unrecognizable. While neither group ...

Forbes contributors publish independent expert analyses and insights. I am a cable news contributor and professor of journalism. This voice experience is generated by AI. Learn more. This voice ...